Skip To Main Content
Campus
  • Terapiområde
Campus
  • Terapiområde
View Full Results
Sort by

Filtera

Återställ
  • Filtera
  • Innehållstyp

Luftvägsremodellering vid astma: Varför det är viktigt att rikta in sig på IL-4 och IL-13

Läs mer

The Evolving Landscape of Disease Modification in Atopic Dermatitis - Current Evidence and Future Directions

Läs mer

The Hematology Podcast - Season 5

Welcome to The Hematology Podcast, your source for the latest insights into hematology and rare blood disorders.

Läs mer

Congress updates

Läs mer

Beyfortus® ▼(nirsevimab): effectiveness and public health impact in the real world

Läs mer

Gaucher disease in children

Gaucher disease is an autosomal recessive lysosomal storage disorder caused by pathogenic variants in the GBA1 gene, resulting in deficient activity of the enzyme acid β glucosidase.
Läs mer

Real-World Evidence and Phase IV studies in CRSwNP

Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally have a high symptom burden and poor health-related quality of life (QoL), often requiring recurring systemic corticosteroid use and repeated sinus surgery.

Läs mer

DUPIREAL: Two-Year Turning Point with Dupilumab in CRSwNP

The results from the DUPIREAL real-world study reinforce the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and are consistent with the approved SmPC.1,2,3,4 DUPIREAL is the largest long-term real-world study (n=926) evaluating the effectiveness of dupilumab, including treatment response, disease control and remission, in severe uncontrolled CRSwNP over 2 years.2,3

Läs mer

Efficacy and safety of dupilumab in patients with PN with or without a history of atopic comorbidities

Läs mer

Expert video: Complex type 2 inflammation, refreshingly simple

Professor Lipworth provides quick insight with the bucket model.

Läs mer

Så skyddar vi våra minsta: sammanfattning från webbinariet om Beyfortus

Läs mer

RSV-prevention med Beyfortus (nirsevimab) – tillgänglig för nyfödda från 10 september

Beyfortus® är en RSV-immunisering designad för alla spädbarn, för skydd mot RSV-sjukdom i de nedre luftvägarna (LRTD).1

Läs mer